Roles of group II metabotropic glutamate receptors in modulation of seizure activity

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 361, Issue 3, 2000, Pages 283-288

  Klodzinska A ^a   Bijak, M ^a   Chojnacka Wojcik E ^a   Kroczka, B ^a   Swiader M ^b   Czuczwar, S J ^b   Pilc, A ^a,c  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Diazepam; Epileptiform discharges Seizures; Group II metabotropic glutamate receptors; LY354740; NMDA; Pentylenetetrazol; Picrotoxin

Indexed keywords

ANTICONVULSIVE AGENT; DIAZEPAM; EGLUMETAD; ETHOSUXIMIDE; GLUTAMATE RECEPTOR AGONIST; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; PENTETRAZOLE; PICROTOXIN; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN CORTEX; CLONIC SEIZURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG MIXTURE; DRUG POTENTIATION; EPILEPTIC DISCHARGE; MOUSE; NONHUMAN; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; BICYCLO COMPOUNDS; BRAIN; CONVULSANTS; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ELECTROPHYSIOLOGY; MALE; MICE; N-METHYLASPARTATE; PENTYLENETETRAZOLE; PICROTOXIN; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; SEIZURES;

EID: 0033953175     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002109900197     Document Type: Article

References (38)

1. Abdul-Ghani AS, Attwell PJ, Singh Kent N, Bradford HF, Croucher MJ, Jane DE (1997) Anti-epileptogenic and anticonvulsant activity of L-2-amino-4-phosphonobutyrate, a presynaptic glutamate receptor agonist. Brain Res 755:202-212
2. Aram JA, Lodge D (1988) Validation of a neocortical slice preparation for the study of epileptiform activity. J Neurosci Methods 23:211-224
3. Attwell PJE, Kent NS, Jane DE, Croucher MJ, Bradford HF (1998a) Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl) glycine (DCG-IV). Brain Res 805:138-143
4. Attwell PJE, Koumentaki A, Abdulghani AS, Croucher MJ, Bradford HF (1998b) Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats. Brain Res. 1998, 787, 286-291
5. 0 in the human epileptogenic neocortex maintained in vitro. Brain Res 417:199-203
6. Bradford HF (1995) Glutamate, GABA and epilepsy. Prog Neurobiol 47:477-511
7. Camon L, Vives P, Devera N, Martinez E (1998) Seizures and neuronal damage induced in the rat by activation of group I metabotropic glutamate receptors with their selective agonist 3,5-dihydroxyphenylglycine. J Neurosci Res 51:339-348
8. Chapman AG, Yip PK, Yap JS, Quinn LP, Tang E, Harris JR, Meldrum BS (1999) Anticonvulsant actions of LY 367385 ((+)-2-methyl-4-carboxyphenylglycine) and AIDA ((R,S)-1-aminoindan-1,5-dicarboxylic acid). Eur J Pharmacol 368:17-24
9. Czuczwar SJ, Meldrum B (1982) Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid. Eur J Pharmacol 83:335-338
10. Czuczwar SJ, Kleinrok Z, Turski WA (1996) Interactions of excitatory amino acid antagonists with conventional antiepileptic drugs. Metabol Brain Dis 11:143-152
11. Czuczwar SJ, Gasior M, Kamiński R, Kleinrok Z, Kozicka M, Ossowska G, Pietrasiewicz T (1998a) GYKI 52466 [1-(4-aminophenyl)-4-metoxy-7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride] and the anticonvulsive activity of conventional antiepileptics in mice. Mol Chem Neuropathol 33: 149-162
12. Czuczwar SJ, Kamiński R, Gasior M, Kozicka M, Zawadzki A, Kleinrok Z (1998b) LY300164, a novel non-NMDA receptor antagonist, potentiates the anticonvulsive activity of antiepileptic drugs. In: Korczyn E, Monduzzi (eds) Proceedings of 4th Congress of the European Society for Clinical Neuropharmacology, Bologna, Italy, 35-39
13. Dalby NO, Thomsen C (1996) Modulation of seizure activity in mice by metabotropic glutamate receptor ligands. J Pharmacol Exp Ther 276:516-522
14. Ghauri M, Chapman AG, Meldrum BS (1996) Convulsant and anticonvulsant actions of agonists and antagonists of group III mGluRs. Neuroreport 7:1469-1474
15. Helton DR, Tizzano JP, Monn JA, Schoepp DD, Kallman MJ (1997) LY354740: a metabotropic glutamate receptor antagonist which ameliorated symptoms of nicotine withdrawal in rats. Neuropharmacology 36:1511-1516
16. Herron CE, Williamson R, Collingridge GL (1985) A selective N-methyl-D-aspartate antagonist depresses epileptiform activity in rat hippocampal slices. Neurosci Lett 61:255-260
17. Horne AL, Harrison NL, Turner JP, Simmonds MA (1986) Spontaneous paroxysmal activity induced by zero magnesium and bicuculline: suppression by NMDA antagonists and GABA mimetics. Eur J Pharmacol 122:231-238
18. Klitgaard H, Laudrup P (1993) Metabotropic excitatory amino acid receptor agonists selectively potentiate behavioral effects induced by ionotropic excitatory amino acid receptor agonists in mice. Eur J Pharmacol 250:9-13
19. Kłodzińska A, Chojnacka-Wójcik E, Pałucha A, Brański P, Popik P, Pilc A (1999) Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models. Neuropharmacology. 38, 1831-1839
20. Konieczny J, Ossowska, K, Wolfarth S, Pilc A (1998) LY354740, a group II metabotropic receptor agonist with potential anti-Parkinsonian properties. Naunyn-Schmiedeberg's Arch Pharmacol 358:500-502
21. Kwak S, Miyamoto M, Ishida M, Shinozaki H (1996) Neurotoxicity of (2S,1'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl)glycine, a potent agonist for class II metabotropic glutamate receptors, in the rat. Neuroscience 73:687-695
22. Martin G, Nie ZG, Siggins GR (1997) Metabotropic glutamate receptors regulate N-methyl-D-aspartate-mediated synaptic transmission in nucleus accumbens. J Neurophysiol 78:3028-3038
23. McDonald JW, Fix AS, Tizzano JP, Schoepp DD (1993) Seizures and brain injury in neonatal rats induced by 1S,3R-ACPD, a metabotropic glutamate receptor agonist. J Neurosci 13:4445-4455
24. Miyamoto M, Ishida M, Shinozaki H (1997) Anticonvulsive and neuroprotective actions of a potent agonist (DCG-IV) for group II metabotropic glutamate receptors against intraventricular kainate in the rat. Neuroscience 77:131-140
25. Monn JA, Valli MJ, Massey SM, Wright RA, Salhoff CR, Johnson BG, Howe T, Alt CA, Rhodes GA, Robey RL, Griffey KR, Tizzano JP, Kallman MJ, Helton DR, Schoepp DD (1997) Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo [3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. J Med Chem 40:528-537
26. Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A (1984) Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307:462-465
27. Petralia RS, Wang YX, Niedzielski AS, Wenthold RJ (1996) The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations. Neuroscience 71:949-976
28. Pilc A, Legutko B, Czyrak A (1996) The enhancement and the inhibition of noradrenaline-induced cyclic AMP accumulation in rat brain by stimulation of metabotropic glutamate receptors. Prog Neuropsychopharmacol Biol Psychiatry 20:673-690
29. Pin JP, Duvoisin R (1995) The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34:1-26
30. Schoepp DD, Johnson BG, Salhoff CR, McDonald JW, Johnston MV (1991) In vitro and in vivo pharmacology of trans- and cis-(+,-)-1-amino-1,3-cyclopentanedicarboxylic acid: dissociation of metabotropic and ionotropic excitatory amino acid receptor effects. J Neurochem 56:1789-1796
31. Sheardown MJ (1992) Metabotropic glutamate receptor agonists reduce epileptiform activity in the rat cortex. Neuroreport 3: 916-918
32. Shigemoto R, Kinoshita A, Wada E, Nomura S, Ohishi H, Takada M, Flor PJ, Neki A, Abe T, Nakanishi S, Mizuno N (1997) Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J Neurosci 17:7503-7522
33. Suzuki K, Mori N, Kittaka H, Iwata Y, Yamada Y, Osonoe K, Niwa S (1996) Anticonvulsant action of metabotropic glutamate receptor agonists in kindled amygdala of rats. Neurosci Lett 204:41-44
34. Tang E, Yip PK, Chapman AG, Jane DE, Meldrum BS (1997) Prolonged anticonvulsant action of glutamate metabotropic receptor agonists in inferior colliculus of genetically epilepsy-prone rats. Eur J Pharmacol 327:109-115
35. Taschenberger H, Roy BL, Lowe DA (1992) Effects of a metabotropic glutamate agonist, trans-ACPD, on cortical epileptiform activity. Neuroreport 3:629-632
36. Thomsen C, Dalby NO (1998) Roles of metabotropic glutamate receptor subtypes in modulation of pentylenetetrazole-induced seizure activity in mice. Neuropharmacology 37:1465-1473
37. Tizzano JP, Griffey KI, Schoepp DD (1995) Induction or protection of limbic seizures in mice by mGluR subtype selective agonists. Neuropharmacology 34:1063-1067
38. Traub RD, Jefferys JG, Whittington MA (1994) Enhanced NMDA conductance can account for epileptiform activity induced by low Mg2+ in the rat hippocampal slice. J Physiol (Lond) 478: 379-393